Coloma Jason V (CIK 1676170) reported 24 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell MAZE (1,375 shares), Sell MAZE (9,852 shares), Sell MAZE (11,282 shares), Sell MAZE (129 shares), Sell MAZE (2,593 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,375 | $37,292 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 9,852 | $259,856 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 11,282 | $293,482 |
| 2026-09-04 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 129 | $3,325 |
| 2026-09-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,593 | $68,214 |
| 2026-09-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 31,908 | $838,785 |
| 2026-09-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Buy | 50,000 | $0 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,439 | $65,157 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 154 | $4,172 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 30,304 | $809,541 |
| 2026-08-05 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,604 | $43,445 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 30,311 | $907,921 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,593 | $77,726 |
| 2026-07-02 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,597 | $48,606 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,953 | $50,778 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,040 | $53,040 |
| 2026-06-24 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 23,865 | $621,683 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 553 | $14,511 |
| 2026-06-03 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 6,090 | $159,558 |
| 2026-05-27 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 4,504 | $117,104 |
| 2026-05-27 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 2,478 | $64,428 |
| 2026-05-27 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 25,582 | $665,644 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 116 | $3,016 |
| 2026-05-18 | Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer | Sell | 1,822 | $47,372 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04